Clear cell renal carcinoma (ccRCC) accounts for ~2.4% of malignancies and is characterized by a Von Hippel–Lindau protein (VHL)-deficiency, resulting in pseudohypoxic, glycolytic tumors [63]. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.